The Platelia Aspergillus antigen enzyme-linked immunosorbent assay (ELISA) (Bio-Rad, Marnes-la-Coquette, France) has become an important tool for the early detection of invasive aspergillosis in immunocompromised patients (4). This ELISA uses a rat monoclonal antibody (EB-A2) which reacts with ␤-(1,5)-galactofuranose, a side chain of galactomannan (GM). Cross-reactivity of the Platelia ELISA with fungi other than Aspergillus was reported previously (2). Over 10 years ago, we discovered cross-reactivity of GM in antibiotics of fungal origin, such as ampicillin-sulbactam and piperacillin, by the Pastorex Aspergillus latex agglutination test, which used the same antibody (1). Industrially produced ␤-lactam antibiotics derived from Penicillium species also showed positive GM values in vivo (5).
fungal supernatant was decanted; 300 l of the supernatant was used in the Aspergillus antigen assay.
All batches of Cancidas (caspofungin) infusion solutions tested were GM positive (cutoff index in serum is currently 0.5), whereas GM detection in Ecalta/Eraxis (anidulafungin) was variable in different batches and Mycamine (micafungin) gave negative test results ( Table 1 ). The median GM indices (n ϭ 3) were 4.4, 0.8, 0.65, Ͻ0.5, and Ͻ0.5 for 70 mg and 50 mg caspofungin, 100 mg anidulafungin, and 50 mg and 100 mg micafungin, respectively. In the supernatants of the fungi used for manufacturing the echinocandins, GM indices were also detected.
Due to the GM content of caspofungin, especially in the 70-mg dose which is used as the loading dose, the detection of circulating GM may be influenced during caspofungin administration. It is important to point out that the concentrations of GM in caspofungin infusion solutions do not reflect the concentrations of GM circulating in the bloodstream. Nevertheless, increases of GM levels have been reported in vivo and in vitro following echinocandin exposure (3). To our knowledge, this is the first report of GM detection in echinocandin preparations. These findings can have meaningful impact for interpretation of GM antigenemia in patients receiving echinocandins, especially caspofungin. Clinical studies are necessary to verify the relevance of positive serum GM levels and concomitant caspofungin administration. a Three batches were tested for each drug and each concentration. b The GM index was estimated by the ratio of the absorbance value to the cutoff value and considered positive when the value was Ն0.5 on repeat testing.
c GM index of the supernatant solution from the ingredient fungus. The fungal species is shown in parentheses.
